🇺🇸 FDA
Patent

US 8030331

Allosteric modulators of metabotropic glutamate receptors

granted A61PA61P25/00A61P25/14

Quick answer

US patent 8030331 (Allosteric modulators of metabotropic glutamate receptors) held by Addex Pharma, S.A. expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18